LDC203974(IMT1B)

  Cat. No.:  DC39817   Featured
LDC203974(IMT1B)
Chemical Structure
2304621-06-3
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
LDC203974(IMT1B) is a highly specific inhibitor of human mitochondrial RNA polymerase (POLRMT) with improved pharmacokinetic profiles than LDC195943(IMT1).
Cas No.: 2304621-06-3
Chemical Name: 3-​Piperidinecarboxylic acid, 1-​[(2R)​-​2-​[[4-​(2-​chloro-​4-​fluorophenyl)​-​2-​oxo-​2H-​1-​benzopyran-​7-​yl]​oxy]​-​1-​oxopropyl]​-​, (3S)​-
Synonyms: LDC203974;LDC 203974;LDC-203974;IMT1B,IMT1-B IMT1 B
SMILES: C1(C(Cl)=CC(F)=CC=1)C1=CC(=O)OC2=C1C=CC(=C2)O[C@@H](C(=O)N1CCC[C@H](C(=O)O)C1)C
Formula: C24H21ClFNO6
M.Wt: 473.88
Purity: >99%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Publication: Small-molecule inhibitors of human mitochondrial DNA transcription-Nature,Published: 16 December 2020
Description:
In Vivo:
In Vitro:
References:
Kinase Assay:
Cell Assay:
Animal Administration:
References:
MSDS
TITLE DOWNLOAD
MSDS_25860_DC39817_2304621-19-8
COA
LOT NO. DOWNLOAD
Cat. No. Product name Field of application
DC60000 WM3835 WM-3835 is a potent and high-specific HBO1 (KAT7 or MYST2) inhibitor and binds directly to the acetyl-CoA binding site of HBO1 33. WM-3835 activates apoptosis while inhibits osteosarcoma (OS) cell proliferation, migration and invasion. WM-3835 has antitumor activity and potently inhibits pOS-1 xenograft growth in mice.
DC55135 LP-184 LP-184 is a highly potent novel alkylating, next-generation analog of irofulven. LP-184 is an DNA damage repair (DDR) inhibitor and and shows broad anti-tumor cytotoxicity across a panel of NSCLC derived cell lines.
DC55130 CDK4 inhibitor compound 12 CDK4 inhibitor compound 12 is a novel inhibitor of CDK4 with the activity 97 μM.
DC55038 BT-2 BT2 is a BCKDC kinase (BDK) inhibitor with an IC50 of 3.19 μM. BT2 binding to BDK triggers helix movements in the N-terminal domain, resulting in the dissociation of BDK from the branched-chain α-ketoacid dehydrogenase complex (BCKDC)[1]. BT2 (compound 4) is also a potent and selective Mcl-1 inhibitor with a Ki value of 59 μM[2].
DC55002 Nifeviroc Nifeviroc is a CCR5 antagonist potentially for treatment of inflammatory responses to HIV type-1 infection
DC55001 ibap iBAP is a first in class inhibitor of BAP1 complex.
DC53131 Sulfopin Sulfopin is a covalent, highly selective inhibitor of Pin1 with Ki of 17 nM in the FP assay. Sulfopin also blocks Myc-driven tumors in vivo without any toxicity.
DC53057 BPH-1358 BPH-1358 (NSC50460) is a potent human farnesyl diphosphate synthase (FPPS) and undecaprenyl diphosphate synthase (UPPS) inhibitor with IC50s of 1.8 μM and 110 nM, respectively, and is active against S. aureus in vitro (MIC ~250 ng/mL).
DC53056 Indophagolin Indophagolin is a potent, indoline-containing autophagy inhibitor (IC50=140 nM). Indophagolin antagonizes the purinergic receptor P2X4 as well as P2X1 and P2X3 with IC50s of 2.71, 2.40 and 3.49 μM, respectively. Indophagolin also antagonizes the Gq-protein-coupled P2Y4, P2Y6, and P2Y11 receptors (IC50s =3.4~15.4 μM). Indophagolin has a strong antagonistic effect on serotonin receptor 5-HT6 (IC50=1.0 μM) and a moderate effect on receptors 5-HT1B, 5-HT2B, 5-HT4e, and 5-HT7.
DC53055 AC-262536 AC-262536 is a selective androgen receptor modulator (SARM, Ki = 5.01 nM). It is also a partial agonist of the androgen receptor (EC50 = 1.58 nM in a luciferase assay).